Glenmede Trust’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$282K Buy
2,288
+140
+7% +$18.4K ﹤0.01% 1176
2025
Q4
$282K Buy
+2,148
New +$252K ﹤0.01% 1171
2024
Q2
Sell
-2,742
Closed -$366K 1385
2024
Q1
$366K Sell
2,742
-209
-7% -$28K ﹤0.01% 1007
2023
Q4
$400K Sell
2,951
-42,756
-94% -$4.93M ﹤0.01% 962
2023
Q3
$6.1M Buy
45,707
+679
+2% +$112K 0.03% 389
2023
Q2
$10.2M Hold
45,028
0.06% 338
2023
Q1
$10.2M Buy
45,028
+2,367
+6% +$484K 0.06% 338
2022
Q4
$8.39M Buy
42,661
+7,255
+20% +$1.5M 0.05% 350
2022
Q3
$6.57M Buy
35,406
+15,934
+82% +$3.15M 0.04% 376
2022
Q2
$3.49M Sell
19,472
-1,904
-9% -$486K 0.02% 447
2022
Q1
$7.26M Buy
21,376
+2,297
+12% +$776K 0.04% 398
2021
Q4
$7.06M Buy
19,079
+427
+2% +$162K 0.03% 397
2021
Q3
$7.36M Buy
18,652
+165
+0.9% +$75.9K 0.04% 379
2021
Q2
$8.51M Sell
18,487
-484
-3% -$195K 0.04% 358
2021
Q1
$7.09M Buy
18,971
+1,094
+6% +$446K 0.04% 355
2020
Q4
$6.43M Buy
17,877
+15,482
+646% +$4.94M 0.04% 371
2020
Q3
$719K Buy
2,395
+33
+1% +$11.4K ﹤0.01% 693
2020
Q2
$850K Sell
2,362
-272
-10% -$87.5K 0.01% 639
2020
Q1
$849K Hold
2,634
﹤0.01% 775
2019
Q4
$849K Sell
2,634
-631
-19% -$191K ﹤0.01% 775
2019
Q3
$965 Sell
3,265
-945
-22% -$279K ﹤0.01% 747
2019
Q2
$1.51K Sell
4,210
-825
-16% -$260K 0.01% 679
2019
Q1
$1.52K Buy
5,035
+1,742
+53% +$508K 0.01% 680
2018
Q4
$959 Buy
3,293
+843
+34% +$261K ﹤0.01% 739
2018
Q3
$873K Sell
2,450
-21
-0.8% -$6.73K ﹤0.01% 776
2018
Q2
$671K Sell
2,471
-910
-27% -$232K ﹤0.01% 780
2018
Q1
$717K Hold
3,381
﹤0.01% 850
2017
Q4
$717K Sell
3,381
-209
-6% -$43K ﹤0.01% 850
2017
Q3
$695K Buy
3,590
+259
+8% +$48.2K ﹤0.01% 837
2017
Q2
$552K Hold
3,331
﹤0.01% 915
2017
Q1
$552K Sell
3,331
-51
-2% -$8.04K ﹤0.01% 915
2016
Q4
$421K Buy
3,382
+165
+5% +$22.2K ﹤0.01% 986
2016
Q3
$567K Sell
3,217
-187
-5% -$29.9K ﹤0.01% 898
2016
Q2
$464K Sell
3,404
-358
-10% -$50.9K ﹤0.01% 949
2016
Q1
$593K Buy
3,762
+781
+26% +$119K ﹤0.01% 865
2015
Q4
$556K Buy
2,981
+35
+1% +$5.65K ﹤0.01% 878
2015
Q3
$503K Buy
2,946
+31
+1% +$6.27K ﹤0.01% 896
2015
Q2
$618K Buy
2,915
+334
+13% +$65.2K ﹤0.01% 866
2015
Q1
$466K Sell
2,581
-144
-5% -$27.1K ﹤0.01% 983
2014
Q4
$489K Buy
2,725
+8
+0.3% +$1.41K ﹤0.01% 970
2014
Q3
$432K Buy
2,717
+75
+3% +$12.5K ﹤0.01% 922
2014
Q2
$458K Buy
2,642
+113
+4% +$16.9K ﹤0.01% 894
2014
Q1
$364K Buy
2,529
+2,000
+378% +$294K ﹤0.01% 973
2013
Q4
$56K Sell
529
-42
-7% -$3.85K ﹤0.01% 1588
2013
Q3
$44K Buy
571
+18
+3% +$1.38K ﹤0.01% 1629
2013
Q2
$40K Buy
+553
New +$35.4K ﹤0.01% 1572

Other funds holding ILMN

Glenmede Trust's ILMN Position: Q1 2026 in Review

Glenmede Trust increased its Illumina (ILMN) stake by 6.5% in Q1 2026, buying an estimated $18.4K and bringing the position to 2,288 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Glenmede Trust first reported a position in ILMN in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.2M in Q2 2023. 844 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • Glenmede Trust held 2,288 shares of Illumina worth $282K as of Q1 2026.
  • Glenmede Trust bought 140 Illumina shares in Q1 2026, an estimated $18.4K.
  • Illumina made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1176 holding.
  • Glenmede Trust first reported a position in Illumina in Q2 2013 and has held it in 46 quarters since.
  • Glenmede Trust's Illumina position peaked at $10.2M in Q2 2023.
  • 844 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.